Table 1 Clinical characteristics of patients according to tumoral dectin-1 expression.

From: Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma

Characteristics

Patients

Tumoral dectin-1 expression

n

%

low

high

P-value

All patients

290

100

181

109

 

Age, years*

range

15–86

  

0.250†

 ≤55

143

49.3

94

49

 

 >55

147

50.7

87

60

 

Gender

    

0.958†

 Female

91

31.4

57

34

 

 Male

199

68.6

124

75

 

Tumor size, cm*

    

0.948†

 ≤4

163

56.2

102

61

 

 >4

127

43.8

79

48

 

Pathological T stage

    

0.031‡

 pT1

183

63.1

122

61

 

 pT2

27

9.3

16

11

 

 pT3

76

26.2

42

34

 

 pT4

4

1.4

1

3

 

Pathological N stage

    

0.495†

 pN0

35

12.1

19

16

 

 pN1

2

0.7

2

0

 

 pNx

253

87.2

   

Distant metastasis

    

0.994†

 No

274

94.5

171

103

 

 Yes

16

5.5

10

6

 

TNM stage

    

0.098‡

 I

177

61.0

117

60

 

 II

23

7.9

14

9

 

 III

70

24.1

39

31

 

 IV

20

6.9

11

9

 

Fuhrman grade

    

0.557‡

 1

31

10.7

19

12

 

 2

214

73.8

136

78

 

 3

42

14.5

25

17

 

 4

3

1.0

1

2

 

Necrosis

    

0.058†

 Absent

251

86.6

162

89

 

 Present

39

13.4

19

20

 

ECOG PS

    

0.312‡

 0

211

72.8

137

74

 

 1

64

22.1

34

30

 

 2

11

3.8

8

3

 

 3

4

1.4

2

2

 
  1. *Split at median; †χ2 test or Fisher’s exact test, ‡Cochran-Mantel-Haenszel χ2 test, P-value <0.05 was regarded as statistically significant; ECOG PS = Eastern Cooperative Oncology Group performance status.
Back to article page